KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Deferred Taxes: 2020-2023

Historic Deferred Taxes for AbCellera Biologics (ABCL) over the last 4 years, with Dec 2023 value amounting to $2.0 million.

  • AbCellera Biologics' Deferred Taxes was N/A to $1.2 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$2.0 million, marking a year-over-year change of. This contributed to the annual value of $2.0 million for FY2023, which is 192.72% up from last year.
  • According to the latest figures from FY2023, AbCellera Biologics' Deferred Taxes is $2.0 million, which was up 192.72% from -$2.1 million recorded in FY2022.
  • In the past 5 years, AbCellera Biologics' Deferred Taxes registered a high of $2.1 million during FY2020, and its lowest value of -$2.1 million during FY2022.
  • For the 3-year period, AbCellera Biologics' Deferred Taxes averaged around -$724,000, with its median value being -$2.0 million (2021).
  • Its Deferred Taxes has fluctuated over the past 5 years, first crashed by 196.19% in 2021, then spiked by 192.72% in 2023.
  • AbCellera Biologics' Deferred Taxes (Yearly) stood at $2.1 million in 2020, then crashed by 196.19% to -$2.0 million in 2021, then dropped by 4.76% to -$2.1 million in 2022, then spiked by 192.72% to $2.0 million in 2023.